Victoria Rutherford
Investor Relations
Replay available
Medexus Pharmaceuticals Inc. (MDP) Q1 2026 Earnings Call
Medexus Pharmaceuticals Inc. (TSX: MDP) Q1 2026 earnings conference call, held 2025-08-13. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Ken D'Entremont
Chief Executive Officer
Brendan Bushman
Chief Financial Officer
Andre Udin
Analyst, Research Capital
Michael Freeman
Analyst, Raymond James
Scott Henry
Analyst, AGP
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Medexus Pharmaceuticals Inc..
Replay transcript excerpt
WEBVTT 00:00:00.267 -- 00:00:05.735 Good morning, everyone, and welcome to the MedExus Pharmaceuticals First Quarter 00:00:05.735 -- 00:00:10.862 2026 Conference Call. At this time, all participants are in 00:00:10.862 -- 00:00:16.710 a listen-only mode, and the floor will be open for questions following the presentation. 00:00:16.710 -- 00:00:21.117 If anyone should require operator assistance during this conference, please press star 00:00:21.117 -- 00:00:26.044 zero on your phone keypad. Please note this conference is being recorded. 00:00:26.044 -- 00:00:31.383 I will now turn the conference over to your host, Victoria Rutherford, Investor Relations. 00:00:31.383 -- 00:00:34.765 Victoria, the floor is yours. 00:00:34.907 -- 00:00:39.893 Thank you, and good morning, everyone. Welcome to the Medexus Pharmaceuticals' 00:00:39.893 -- 00:00:45.199 first fiscal quarter 2026 earnings call. On the call this morning are Ken John-Tremont, 00:00:45.199 -- 00:00:49.484 Chief Executive Officer, and Brendan Bushman, Chief Financial Officer. 00:00:49.484 -- 00:00:53.248 If you have any questions after the conference call or would like further information 00:00:53.248 -- 00:00:59.817 about the company, please contact Adelaide Capital at 480- I would 00:01:00.900 -- 00:01:04.784 like to remind everyone that this discussion will include forward-looking information 00:01:04.784 -- 00:01:09.488 as defined in Canadian securities laws that is based on certain assumptions that Medexis 00:01:09.488 -- 00:01:15.293 believes to be reasonable in the circumstances but is subject to risks and uncertainties. 00:01:15.293 -- 00:01:20.258 Actual results may differ materially from historical results or results anticipated by 00:01:20.258 -- 00:01:25.523 the forward-looking information. In additi...